Gene-editing technique to treat lung cancer is due to be tested in people in August
Chinese scientists are on the verge of being first in the world to inject people with cells modified using the CRISPR–Cas9 gene-editing technique.
A team led by Lu You, an oncologist at Sichuan University’s West China Hospital in Chengdu, plans to start testing such cells in people with lung cancer next month. The clinical trial received ethical approval from the hospital’s review board on July 6.
“It’s an exciting step forward,” says Carl June, a clinical researcher in immunotherapy at the University of Pennsylvania in Philadelphia.
Sichuan University (SCU) is one of the national universities directly under the Ministry of Education (MOE). It is also one of the State 211 Project and 985 Project universities enjoying privileged construction in the Ninth Five-Year Plan period.
The president of the university is Professor Xie Heping, an academician of the Chinese Academy of Engineering.